March 2, 2017 / 7:07 AM / 5 months ago

BRIEF-Merck says NICE expands a positive recommendation for Erbitux

1 Min Read

March 2 (Reuters) - Merck KGaA

* Says NICE expands positive recommendation for Erbitux as first-line treatment for RAS Wild-type mCRC Source text: here$FILE/Erbitux_NICE_Eng.pdf Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below